Skip to main content
Springer Nature Link
Log in

Experiencing financial toxicity associated with cancer in publicly funded healthcare systems: a systematic review of qualitative studies

  • Review
  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

Understanding how patients and families experience, respond to, and cope with the financial burden associated with cancer could assist in identifying future research priorities and developing relevant interventions to assist patients and families facing financial hardship. This systematic review offers a synthesis of the qualitative evidence on cancer-related financial toxicity from the perspective of patients and/or informal caregivers in publicly funded healthcare systems where it might be expected that financial protection would be strongest.

Methods

Articles published between January 1, 2005, and March 7, 2019, describing financial burden experienced by cancer patients and/or informal caregivers were identified using OVID MEDLINE Embase and PsychInfo, CINAHL, Business Source Complete, and EconLit databases. English language, peer-reviewed qualitative papers describing studies conducted in countries with predominantly publicly funded healthcare systems were eligible. Quality appraisal was conducted using CASP Quality Appraisal Checklist. Narrative synthesis was completed with extracted data and themes identified inductively by all team members.

Results

Twelve articles were identified as eligible. Articles reported on 10 studies conducted in Australia (n = 2), Canada (n = 2), England (n = 3), and Ireland (n = 3). The papers illustrate the complexity and multifaceted nature of experiencing financial hardship following a cancer diagnosis. Each contributes to the whole picture, providing different viewpoints regarding various and diverse forms of financial hardship, the process of confronting financial challenges, working to overcome difficulties, and coping with the resulting impacts. Synthesis of the studies suggested five themes: household and medical costs are increased, financial resources are reduced, financial change and financial hardship vary, financial hardship has many consequences, various mitigation strategies are used.

Conclusion

Cancer patients and their families can experience a broad range of impacts when they are facing and coping with financial toxicity. Consistent gaps in support highlight that strategies to mitigate financial effects related to travel, accommodation, medications, family support, and income replacement are needed for many patients and families even in the context of publicly funded healthcare systems.

Implications for Cancer Survivors

Survivors need to be informed early in their cancer experience about the potential financial burden associated with cancer treatment and its impact on survivors and their family members.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Fitch MI. Supportive Care Framework. Can Oncol Nurs J. 2008;18(1):6–14.

    Article  Google Scholar 

  2. Amir Z, Wilson K, Hennings J, Young A. The meaning of cancer: implications for family finances and consequent impact on lifestyle, activities roles and relationships. Psycho-Oncology. 2012;21:1167–74. https://doi.org/10.1002/pon.2021.

    Article  PubMed  Google Scholar 

  3. Fitch MI, Zomer S, Lockwood G, Louzado C, Shaw-Moxam R, Green E. Experiences of adult cancer survivors in transition. Support Care Cancer. 2019;27:2977–86. https://doi.org/10.1007/s00520-018-4605-3.

    Article  PubMed  Google Scholar 

  4. Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst. 2017;109:djw205. https://doi.org/10.1093/jnci/djw205.

    Article  PubMed  Google Scholar 

  5. Azzani M, Roslani AC, Tin Tin S. The perceived cancer-related financial hardship among patients and their families: a systematic review. Support Care Cancer. 2015;23(3):889–98. https://doi.org/10.1007/s00520-014-2474-y.

    Article  PubMed  Google Scholar 

  6. Zafar SY, Abernethy AP. Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80–149.

    Google Scholar 

  7. Hanly P, Ceilleachair AO, Skally M, O’Leary E, Kapur K, Fitzpatrick P, et al. How much does it cost to care for survivors of colorectal cancer? Caregiver’s time, travel and out-of-pocket costs. Support Care Cancer. 2013;21(9):2583–92. https://doi.org/10.1007/s00520-013-1834-3.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Longo CJ, Fitch M, Deber RB, Williams AP. Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer. 2006;14(11):1077–85.

    Article  Google Scholar 

  9. Lauzier S, Maunsell E, Konnick M, Drole M, Heber-Croleau N, Robert J. Conceptualization and sources of costs from breast cancer: Findings from patients and caregiver focus groups. Psycho-oncology. 2005;14:351–60. https://doi.org/10.1002/pon.851.

    Article  PubMed  Google Scholar 

  10. Sharp L, O’Leary E, O’Ceilleachair A, Skally M, Hanly P. Financial impact of colorectal cancer and its consequences: associations between cancer-related financial stress and strain and health-related quality of life. Dis Colon Rectum. 2018;61(1):27–35. https://doi.org/10.1097/DCR.0000000000000923.

    Article  PubMed  Google Scholar 

  11. Tran G, Zafar SY. Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med. 2018;6(9). https://doi.org/10.21037/atm.2018.03.28.

  12. Reeves A, McKee M, Basu S, Stuckler D. The political economy of austerity and healthcare: cross-national analysis of expenditure changes in 27 European Nations. 1995–2011. Health Policy. 2014;115(1):1–8. https://doi.org/10.1016/j.healthpol.2013.11.008.

    Article  PubMed  Google Scholar 

  13. Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL, et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013;119(20):3710–7. https://doi.org/10.1002/cncr.28262.

    Article  PubMed  Google Scholar 

  14. Torp S, Nielsen RA, Gudbergsson SB, Dahl AA. Worksite adjustments and work ability among employed cancer survivors. Support Care Cancer. 2012;20(9):2149–56. https://doi.org/10.1007/s00520-011-1325-3.

    Article  PubMed  Google Scholar 

  15. Fitch MI, Nicol I. Return to work after cancer: patients’, caregivers’ and employers’ perspectives. Psycho-Oncology. 2019;28(4):792–298.

    Article  Google Scholar 

  16. Swanberg JE. Making it work. J Psychosoc Oncol. 2006;24(3):1–18. https://doi.org/10.1300/J077v24n03_01.

    Article  PubMed  Google Scholar 

  17. Gordon LG, Merollini KMD, Lowe A, Chan RJ. A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient. 2016;10:295–309. https://doi.org/10.1007/s40271-016-0204-x.

    Article  Google Scholar 

  18. Smith GL, Lopez-Olivo MA, Advani PG, Ning MS, Geng Y, Giordano SH, et al. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Cancer Netw. 2019;17:1184–92. https://doi.org/10.6004/jnccn.2019.7305.

    Article  Google Scholar 

  19. Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin. 2018;68:153–65. https://doi.org/10.3322/caac.21443.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Longo CJ, Fitch MI, Banfield L, Hanly P, Tabroff KR, Sharp L. Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review. Support Care Cancer. 2020;28:4645–65. https://doi.org/10.1007/s00520-020-05620-9.

    Article  PubMed  Google Scholar 

  21. World Health Organization: International Agency for Research on Cancer, cancer incidence list by tumour type for the world. http://gco.iarc.fr/today/explore (Multibar option); (HDI country list 2018 http://hdr.undp.org/en/content/human-development-index-hdi). Accessed 7 Feb 2019.

  22. Critical Appraisal Skill Programme. 10 questions to help you make sense of qualitative research. Available at http://www.casp-uk.net/wp-content/uploads/2011/11/CASP-Qualitative-Research-Checklist-31.05.13.pdf. Accessed 2019, December 20.

  23. Noblit GW, Hare RD. Meta-ethnography: synthesizing qualitative studies. Newbury Park: Sage; 1988.

    Book  Google Scholar 

  24. Popay J, Roberts H, Sowden A, Pettcrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. Economic and Social Research Council: Swindon; 2006.

    Google Scholar 

  25. Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8:45. https://doi.org/10.1186/1471-2288-8-45.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Barnett-Page E, Thomas J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol. 2009;9:59. https://doi.org/10.1186/1471-2288-9-59.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Snilstveit B, Oliver S, Vojtkova M. Narrative approaches to systematic review and synthesis of evidence for international development policy and practice. J Dev Effect. 2012;4(3):409–29. https://doi.org/10.1080/19439342.2012.710641.

    Article  Google Scholar 

  28. Hegney D, Pearce S, Roger-Clark C, Martin-McDonald K, Buikstra E. “Close, but still too far”: the experience of Australian people with cancer commuting from a regional to a capital city for radiation treatment. Eur J Cancer Care. 2005;14:75–82.

    Article  CAS  Google Scholar 

  29. Shahid S, Finn L, Bessarah D, Thompson S. “Nowhere to room…nobody told them”: logistical and cultural impediments to Aboriginal peoples’ participation in cancer treatment. Aust Health Rev. 2011;35:235–41. https://doi.org/10.1071/AH09835.

    Article  PubMed  Google Scholar 

  30. Moffat S, Noble E, Exley C. “Done more for me in a fortnight than anybody done in all me life.” How welfare rights advice can help people with cancer. BMC Health Sci Res. 2010;10:259 http://www.biomedcentral.com/1472-6963/10/259. Accessed 12 Dec 2019.

  31. Moffat S, Noble E, White M. Addressing the financial consequences of cancer: qualitative evaluation of a welfare rights advice service. PLoS One. 2012;7(8):e42979. https://doi.org/10.1371/journal.pone.0042979.

    Article  CAS  Google Scholar 

  32. O’Ceilleachair AO, Costello L, Finn C, Timmons A, Fitzpatrick P, Kapur K, et al. Inter-relationships between the economic and emotional consequences of colorectal cancer for patients and their families: a qualitative study. BMC Gastroenterol. 2012;12:62 http://www.biomedcentral.com/1471-230X/12/62. Accessed 15 Dec 2019.

  33. Timmons A, Gooberman-Hill R, Sharp L. “It’s at a time in your life when you are most vulnerable”: a qualitative exploration of the financial impact of a cancer diagnosis and implications for financial protection in health. PLoS One. 2013;8(11):e77549 www.plosone.org. Accessed 15 Dec 2019.

  34. Timmons A, Gooberman-Hill R, Sharp L. The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public-private healthcare system. Support Care Cancer. 2013;21:107–17. https://doi.org/10.1007/s00520-012-1498-4.

    Article  PubMed  Google Scholar 

  35. Byrne J, Campbell H, Gilchrist M, Summersby E, Hennessy B. Barriers to care for breast cancer: a qualitative study in Ireland. Eur J Cancer Care. 2018;27:e12876. https://doi.org/10.1111/ecc.12876.

    Article  Google Scholar 

  36. Longo CJ, Fitch MI, Girgnon M, McAndrew A. Understanding the full breadth of cancer related patient costs in Ontario: a qualitative exploration. Support Care Cancer. 2016;24(11):4541–8. https://doi.org/10.1007/s00520-016-3293-0.

    Article  PubMed  Google Scholar 

  37. Fitch M, Longo CJ. Exploring the impact of out-of-pocket costs on the quality of life of Canadian cancer patients. J Psychosoc Oncol. 2018;31(5):582–96. https://doi.org/10.1080/07347332.2018.1486937.

    Article  Google Scholar 

  38. O’Ceilleachair A, Hanley P, Skally M, O’Leary E, O’Neill C, Fitzpatrick P, et al. Counting the cost of cancer: out-of-pocket payments made by colorectal cancer survivors. Support Care Cancer. 2017;25(9):2733–41. https://doi.org/10.1007/s00520-017-3683-y.

    Article  Google Scholar 

  39. Valtorta N, Hanratty B. Socioeconomic variation in the financial consequences of ill health for older people with chronic diseases: a systematic review. Maturitas. 2013;74(4):313–33. https://doi.org/10.1016/j.maturitas.2013.01.015.

    Article  PubMed  Google Scholar 

  40. Coughlin SS, Dean LT. Cancer survivorship care plans, financial toxicity, and financial planning alleviating financial distress among cancer survivors. Support Care Cancer. 2019;27(6):1969–71. https://doi.org/10.1007/s00520-019-04703-6.

    Article  PubMed  PubMed Central  Google Scholar 

  41. deSouza JA, Yap BJ, Wroblewski K, Blinder V, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome The validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017;123(3):476–84. https://doi.org/10.1002/cncr.30369.

    Article  Google Scholar 

  42. Mierzynska J, Piccinin C, Pe M, Martinelli F, Gotay C, Coens C, et al. Prognostic value of patient-reported outcomes from international randomized controlled trials on cancer: a systematic review. Lancet Oncol. 2019;20(12):E685–98 https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30656-4/fulltext. Accessed 01/03/2020.

  43. Binka C, Nyarko SH, Awusabo-Asare K, Doku DT. “I always tried to forget about the condition and pretend I was healed”: coping with cervical cancer in rural Ghana. BMC Palliat Care. 2018;17(1):24. https://doi.org/10.1186/s12904-018-0277-5.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Owenga JA, Nyambedha EO. Perception of cervical cancer patients on their financial challenges in Western Kenya. BMC Health Serv Res. 2018;18(1):261. https://doi.org/10.1186/s12913-018-3073-2.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Hassankhani H, Eghtedar S, Rahmani A, Ebrahimi H, Whitehead B. A qualitative study on cancer care burden: experiences of Iranian Family Caregivers. Holist Nurs Pract. 2019;33(1):17–26. https://doi.org/10.1097/HNP.0000000000000309.

    Article  PubMed  Google Scholar 

  46. Head B, Harris L, Kayser K, Martin A, Smith L. As if disease was not enough: coping with the financial consequences of cancer. Support Care Cancer. 2018;26:975–87. https://doi.org/10.1007/s00520-017-3918-y.

    Article  PubMed  Google Scholar 

  47. Chebli P, Lemus J, Avila C, et al. Multilevel determinants of financial toxicity in breast cancer care: perspectives of healthcare professionals and Latina survivors. Support Care Cancer. 2020;28(7):3179–88. https://doi.org/10.1007/s00520-019-05119-y.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge and thank Laura Banfield, Librarian, McMaster University, for her assistance with the search of the literature.

Author information

Authors and Affiliations

  1. Bloomberg Faculty of Nursing, University of Toronto, 207 Chisholm Ave, Toronto, Ontario, Canada

    Margaret I. Fitch

  2. Population Health Sciences Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK

    Linda Sharp

  3. National College of Ireland, Dublin, Ireland

    Paul Hanly

  4. Health Policy and Management, DeGroote School of Business, McMaster University, Hamilton, Ontario, Canada

    Christopher J. Longo

Authors
  1. Margaret I. Fitch
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Linda Sharp
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Paul Hanly
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Christopher J. Longo
    View author publications

    You can also search for this author inPubMed Google Scholar

Contributions

Conceptualization/plan of the review: CL, MF, LS, PH

Article review for eligibility: MF, LS, PH, CL

Article review for quality: MF, LS, PH

Data extraction qualitative articles/initial review: MF

Data review/design of themes: CL, MF, LS, PH

Initial draft of manuscript: MF

Review/revision/final approval of manuscript: CL, MF, LS, PH

Corresponding author

Correspondence to Margaret I. Fitch.

Ethics declarations

Ethics approval

None require

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fitch, M.I., Sharp, L., Hanly, P. et al. Experiencing financial toxicity associated with cancer in publicly funded healthcare systems: a systematic review of qualitative studies. J Cancer Surviv 16, 314–328 (2022). https://doi.org/10.1007/s11764-021-01025-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-021-01025-7

Keywords